Halozyme Therapeutics
HALO
#2058
Rank
C$10.17 B
Marketcap
$80.31
Share price
-3.01%
Change (1 day)
50.53%
Change (1 year)

EPS for Halozyme Therapeutics (HALO)

EPS in 2023 (TTM): $2.35

According to Halozyme Therapeutics's latest financial reports the company's current EPS (TTM) is $2.36. In 2022 the company made an earnings per share (EPS) of $2.01 a decrease over its 2021 EPS that were of $3.87.

EPS history for Halozyme Therapeutics from 2002 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.3517.08%
2022$2.01-48.07%
2021$3.87196.88%
2020$1.30-292%
2019-$0.68-9.09%
2018-$0.75-237.5%
2017$0.54-149.38%
2016-$1.10211.54%
2015-$0.35-52.73%
2014-$0.75-24.66%
2013-$0.9948.98%
2012-$0.66145%
2011-$0.27-64.29%
2010-$0.76-17.65%
2009-$0.929.68%
2008-$0.8493.75%
2007-$0.4333.33%
2006-$0.33-4%
2005-$0.34-3.85%
2004-$0.35-13.33%
2003-$0.4183.59%
2002-$0.22

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$0.26-110.92%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.36 212.03%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.94 194.25%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.52 6.90%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.31 82.77%๐Ÿ‡ซ๐Ÿ‡ท France
$19.11 709.50%๐Ÿ‡บ๐Ÿ‡ธ USA